Related Experiment Video
Updated: Jul 9, 2026
10:17
An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
Published on: November 3, 2010
Genetics of clinical expression in SLE
Bahram Namjou1, Jeff Kilpatrick, John B Harley
1Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Autoimmunity
|December 14, 2007
Summary
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with unknown pathogenesis. Recent genetic studies highlight the role of cytokines and interferons in SLE immune dysregulation, confirming new genetic associations.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by a loss of self-tolerance.
- Its pathogenesis involves genetic, hormonal, and environmental factors, leading to diverse clinical manifestations and autoantibody profiles.
- Despite extensive research, the detailed mechanisms underlying SLE remain incompletely understood.
Purpose of the Study:
- To explore the genetic underpinnings of Systemic Lupus Erythematosus.
- To investigate the role of specific immune system components in SLE pathogenesis.
- To validate genetic associations for SLE across different populations.
Main Methods:
- Analysis of gene expression data to identify key immune regulators.
- Application of high-throughput single-nucleotide polymorphism (SNP) genotyping for genetic association studies.
- Cross-population validation of identified genetic associations.
Main Results:
- Gene expression analyses strongly implicate cytokines and interferons in SLE-related immune dysregulations.
- Advances in SNP genotyping have facilitated practical genetic association studies for SLE.
- New genetic associations for SLE have been confirmed in diverse populations for the first time.
Conclusions:
- Cytokines and interferons play a direct role in the immune dysregulation observed in SLE.
- Modern genetic technologies enable robust association studies for complex diseases like SLE.
- Confirmed genetic associations provide a foundation for further understanding SLE etiology and potential therapeutic targets.
Related Concept Videos
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:11Genetic Lingo
Overview